4 years ago

CytoSeek Secures £3.5M Seed Funding to Advance Cell Therapy Cancer Treatment

  • Bristol-based biotech startup CytoSeek has raised £3.5 million in seed funding to further develop its Artificial Membrane Binding Protein (AMPB) technology for treating solid tumours

  • The round was led by Science Creates Ventures and saw participation from Parkwalk, Melltwind, Luminous Ventures, UKI2S, and angel investors.

      • ProblemHealthcare

      "Current cancer treatments for solid tumours are often ineffective and have severe side effects. "

      Solution

      "CytoSeek is developing a new type of cell therapy that uses Artificial Membrane Binding Proteins (AMPBs) to target and destroy cancer cells. This technology is designed to be more effective and have fewer side effects than existing treatments."

      Covered on